Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · IEX Real-Time Price · USD
405.63
+5.71 (1.43%)
Apr 23, 2024, 11:33 AM EDT - Market open
Vertex Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9,869 | 8,931 | 7,574 | 6,206 | 4,163 | 3,048 | 2,489 | 1,702 | 1,032 | 580.42 | Upgrade
|
Revenue Growth (YoY) | 10.51% | 17.91% | 22.06% | 49.08% | 36.59% | 22.46% | 46.20% | 64.89% | 77.86% | -52.11% | Upgrade
|
Cost of Revenue | 1,262 | 1,080 | 904.2 | 736.3 | 547.8 | 409.54 | 275.12 | 210.46 | 124.51 | 60.99 | Upgrade
|
Gross Profit | 8,607 | 7,850 | 6,670 | 5,469 | 3,615 | 2,638 | 2,214 | 1,492 | 907.82 | 519.43 | Upgrade
|
Selling, General & Admin | 1,137 | 944.7 | 840.1 | 770.5 | 658.5 | 557.62 | 496.08 | 432.83 | 376.58 | 305.41 | Upgrade
|
Research & Development | 3,163 | 2,540 | 1,938 | 1,645 | 1,755 | 1,416 | 1,325 | 1,048 | 995.92 | 855.51 | Upgrade
|
Other Operating Expenses | 527.1 | 115.5 | 1,113 | 184.6 | 0 | 28.82 | 269.59 | 1.26 | 2.21 | 50.93 | Upgrade
|
Operating Expenses | 4,827 | 3,601 | 3,891 | 2,600 | 2,413 | 2,003 | 2,090 | 1,482 | 1,375 | 1,212 | Upgrade
|
Operating Income | 3,780 | 4,250 | 2,779 | 2,869 | 1,202 | 635.15 | 123.24 | 9.94 | -466.88 | -692.41 | Upgrade
|
Interest Expense / Income | 44.1 | 54.8 | 61.5 | 58.2 | 58.5 | 72.47 | 69.3 | 81.43 | 84.21 | 72.86 | Upgrade
|
Other Expense / Income | -643.5 | -37.3 | -12.9 | -305.7 | -251.4 | -47.36 | -102.22 | 23.89 | -25.13 | -33.68 | Upgrade
|
Pretax Income | 4,380 | 4,232 | 2,730 | 3,117 | 1,395 | 610.03 | 156.16 | -95.39 | -525.95 | -731.6 | Upgrade
|
Income Tax | 760.2 | 910.4 | 388.3 | 405.2 | 218.1 | -1,486.86 | -107.32 | 16.67 | 30.38 | 6.96 | Upgrade
|
Net Income | 3,620 | 3,322 | 2,342 | 2,712 | 1,177 | 2,097 | 263.48 | -112.05 | -556.33 | -738.56 | Upgrade
|
Net Income Growth | 8.96% | 41.84% | -13.63% | 130.43% | -43.88% | 695.83% | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 258 | 256 | 258 | 260 | 257 | 254 | 249 | 245 | 241 | 235 | Upgrade
|
Shares Outstanding (Diluted) | 261 | 259 | 260 | 263 | 261 | 259 | 253 | 245 | 241 | 235 | Upgrade
|
Shares Change | 0.54% | -0.31% | -1.33% | 1.04% | 0.58% | 2.35% | 3.49% | 1.40% | 2.55% | 4.62% | Upgrade
|
EPS (Basic) | 14.05 | 12.97 | 9.09 | 10.44 | 4.58 | 8.24 | 1.06 | -0.46 | -2.31 | -3.14 | Upgrade
|
EPS (Diluted) | 13.89 | 12.82 | 9.01 | 10.29 | 4.51 | 8.09 | 1.04 | -0.46 | -2.31 | -3.14 | Upgrade
|
EPS Growth | 8.35% | 42.29% | -12.44% | 128.16% | -44.25% | 677.88% | - | - | - | - | Upgrade
|
Free Cash Flow | 3,337 | 3,925 | 2,409 | 2,994 | 1,494 | 1,175 | 745.52 | 179.54 | -410.73 | -624.31 | Upgrade
|
Free Cash Flow Per Share | 12.95 | 15.33 | 9.35 | 11.52 | 5.82 | 4.62 | 3.00 | 0.73 | -1.70 | -2.65 | Upgrade
|
Gross Margin | 87.21% | 87.90% | 88.06% | 88.14% | 86.84% | 86.56% | 88.95% | 87.64% | 87.94% | 89.49% | Upgrade
|
Operating Margin | 38.31% | 47.59% | 36.69% | 46.24% | 28.87% | 20.84% | 4.95% | 0.58% | -45.23% | -119.30% | Upgrade
|
Profit Margin | 36.68% | 37.20% | 30.92% | 43.70% | 28.27% | 68.80% | 10.59% | -6.58% | -53.89% | -127.25% | Upgrade
|
Free Cash Flow Margin | 33.81% | 43.95% | 31.80% | 48.24% | 35.89% | 38.55% | 29.96% | 10.55% | -39.79% | -107.56% | Upgrade
|
Effective Tax Rate | 17.36% | 21.51% | 14.22% | 13.00% | 15.64% | -243.73% | -68.73% | - | - | - | Upgrade
|
EBITDA | 4,605 | 4,436 | 2,918 | 3,285 | 1,560 | 754.93 | 286.86 | 47.44 | -379.4 | -595.48 | Upgrade
|
EBITDA Margin | 46.66% | 49.67% | 38.52% | 52.93% | 37.48% | 24.77% | 11.53% | 2.79% | -36.75% | -102.60% | Upgrade
|
Depreciation & Amortization | 181.3 | 148.3 | 125.6 | 109.5 | 106.9 | 72.42 | 61.4 | 61.4 | 62.34 | 63.26 | Upgrade
|
EBIT | 4,424 | 4,287 | 2,792 | 3,175 | 1,453 | 682.51 | 225.46 | -13.96 | -441.75 | -658.73 | Upgrade
|
EBIT Margin | 44.83% | 48.01% | 36.86% | 51.16% | 34.91% | 22.39% | 9.06% | -0.82% | -42.79% | -113.49% | Upgrade
|